EZHITSCREEN
DEAD

Serial Number

76223043

Owner

Mermaid Pharmaceuticals GmbH

Attorney

Talivaldis Cepuritis

Filing Date

Mar 12, 2001

Add to watchlist:

No watchlists yet
View on USPTO

EZHITSCREEN Trademark

Serial Number: 76223043

EZHITSCREEN is a trademark filed by Mermaid Pharmaceuticals GmbH on March 12, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Mermaid Pharmaceuticals GmbH (12 trademarks)

Lagerstr. 11
20357 Hamburg , DE

Entity Type: 03

Trademark Details

Filing Date

March 12, 2001

Registration Date

Not Registered

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS OR TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC,CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATED, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC OR CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS FOR CLINICAL, LABORATORY, MEDICAL AND CHEMICAL USE TO DIAGNOSE, PROGNOSE, PREDICT OR TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS FOR EVALUATING EFFICACY OF TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE

DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES,AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR SCIENTIFIC OR RESEARCH USE

RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING,PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY,EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS

Filing History

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 19, 2004 ABN2
INQUIRY AS TO SUSPENSION MAILED
Oct 14, 2003 CNSI
LETTER OF SUSPENSION MAILED
Jan 31, 2003 CNSL
ASSIGNED TO EXAMINER
Oct 17, 2002 DOCK
ASSIGNED TO EXAMINER
Aug 20, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2002 CRFA
NON-FINAL ACTION MAILED
Aug 10, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2001 DOCK
ASSIGNED TO EXAMINER
Jul 16, 2001 DOCK
ASSIGNED TO EXAMINER
Jun 29, 2001 DOCK